By IANS,
New Delhi : The Bangalore-based pharmaceutical firm Strides Arcolab Tuesday said two more of its drugs have been approved by the US Food and Drug Administration.
With this, the total approvals in the US have risen to 11, the company said in a statement.
The latest drugs to receive approvals are the Dexamethasone injection and Dexamethasone Sodium Phosphate injection.
The products are licensed to Akorn-Strides LLC, a joint venture with the US-based Akorn Inc, it said.